Insiders Femasys Inc.

Equities

FEMY

US31447E1055

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-14 EDT			5-day change	1st Jan Change
1.38 ^USD	+8.66%		-2.82%	+41.54%

05-09	Femasys Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-09	Earnings Flash (FEMY) FEMASYS Reports Q1 Revenue $271,140	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Femasys Inc. Appoints Richard Spector as Chief Commercial Officer	02-06	CI
Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer	11-30	CI
Femasys Inc. Appoints Joshua Silverman as Director	11-21	CI
Femasys Inc. Designates Daniel Currie as its Chief Operating Officer	23-08-10	CI
Femasys Inc. Announces Management Changes	23-06-15	CI
Femasys Inc. Appoints Christine Thomas as Senior Vice President of Regulatory and Clinical Affairs, Effective October 10, 2022	22-10-12	CI
Femasys Inc. Announces Board Changes	22-07-06	CI
Femasys Names Dov Elefant as CFO	22-02-24	MT
Femasys Inc. Appoints Dov Elefant to Chief Financial Officer, Effective February 28, 2022	22-02-24	CI
Femasys Inc. Announces the Appointment of Wendy Perrow, Transformational Biotech Entrepreneur, as New Board Member	22-01-20	CI
Femasys Inc. Announces the Appointment of Edward Evantash as Chief Medical Officer	21-09-01	CI
Femasys Appoints Fred Aslan and Charles Larsen to its Board of Directors	16-03-23	CI
Femasys Inc. Appoints Todd Creech as Chief Financial Officer	15-12-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW